Serial Number | 79311207 |
Word Mark | TICEBA STEM CELL EXPERTS |
Filing Date | Tuesday, December 22, 2020 |
Status | 700 - REGISTERED |
Status Date | Tuesday, October 4, 2022 |
Registration Number | 6861489 |
Registration Date | Tuesday, October 4, 2022 |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, July 19, 2022 |
Goods and Services | pharmaceutical drugs, namely pharmaceutical drugs for treatment of skin diseases, antibiotics, immune suppressants, anti-inflammatory pharmaceuticals; pharmaceutical drugs for treatment of disease and disorders of the respiratory system, the gastrointestinal system, the endocrine system, the cardiovascular system, the nervous system, the musculoskeletal system, the urinary system, the integumentary system, the reproductive system, for the treatment of blood diseases and disorders; pharmaceutical drugs for treatment of cancer, hormone replacement therapy preparations; pharmaceutical and veterinary preparations for treatment of vertigo, migraine, nausea, vomiting, for treatment of skin diseases, wound healing, pharmaceutical and veterinary preparations for treating diabetes, antidepressants; pharmaceutical preparations for anti-aging, pharmaceutical preparations namely antibiotics, vaccines; diagnostic agents for medical use; preparations for medical purposes, namely, for the treatment of skin diseases, allergy medication, herbal extracts for medical use, reagents for medical use; substances for medical use, namely, for regeneration of tissue and anti-inflammation; stem cells for medical purposes; stem cells for veterinary purposes; stem cells for aesthetic purposes, namely, for anti-aging, for use in dermatology procedures; somatic stem cell therapeutics, namely, for medical therapeutic use; fibroblasts for medical use; fibroblasts for aesthetic purposes, namely, for use in dermatology procedures; pharmaceutical implants, namely, implantable subcutaneous drug delivery devices sold filled with pharmaceutical for treatment of skin diseases, blood diseases, vertigo, nausea, vomiting, migraine, respiratory system, the gastrointestinal system, the endocrine system, the cardiovascular system, the musculoskeletal system, the urinary system, the integumentary system, and the reproductive system; surgical implants derived from stem cells, namely, surgical implants derived from living tissues and living stem cells; surgical implants derived from fibroblasts, namely, surgical implants comprised of living fibroblasts tissue cells; biological tissue for implantation, namely, implants comprising living tissues; cell growth media for growing cells for medical use; pharmaceutical preparations for tissue regeneration; vascular grafts; living tissue, namely, surgical implants comprised of living tissues; biotechnologically engineered tissue products, namely, living tissue cell sheets and plasters for wound healing and burns, biological eye lens grafts, bone grafts in the nature of biological bone tissue for grafting, biological tissue grafts, human allograft tissue |
Goods and Services | Stem cells for scientific or research use; cell growth media for growing cells for scientific use |
Goods and Services | Medical services relating to the removal, treatment, processing and preservation of human blood, cord blood, human cells and tissue, stem cells and bone marrow, also in the field of regenerative medicine, including tissue engineering; medical services in connection with the removal, treatment and processing of human tissue and stem cells, human tissue and stem cell bank services, including in the field of regenerative medicine, including tissue engineering; medical services relating to the cultivation and extraction of stem cells; medical services in connection with the cultivation and extraction of stem cells |
Disclaimer with Predetermined Text | "STEM CELL EXPERTS" |
Goods and Services | Stem cell research; scientific research and development and medical research and development in the field of stem cells, vaccines and medications; scientific research, testing and analysis services in the field of regenerative medicine and tissue engineering, genetics and genetic engineering; scientific research for medical purposes; medical research; research and development of new products for others; consultancy in the field of pharmaceutical research; providing information on medical and scientific research on pharmaceutical products; biomedical research; preparation of reports relating to scientific research, namely, technical writing for others; research in the field of biotechnology; research in the field of gene therapy; research and development in the field of immunology; research and development in the field of antibodies; research and development in the field of antibody technology; research and development in the field of bacteriology; research and development in the field of gene expression systems; research and development in the field of vaccines; research and development services for the pharmaceutical industry; research and development services in the field of biotechnology; development of industrial processes, namely, engineering of industrial processes in the field of for packaging, storage and transport of human tissue and human adult ancestral cells, engineering of industrial processes to manufacture stem cells; industrial process research in the field of regenerative medicine and tissue engineering, chemical engineering |
International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
US Class Codes | 001, 005, 006, 010, 026, 046 |
Class Status Code | 6 - Active |
Class Status Date | Friday, May 21, 2021 |
Primary Code | 001 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, May 21, 2021 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, May 21, 2021 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Friday, May 21, 2021 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | NOT AVAILABLE |
Party Type | 30 - Original Registrant |
Legal Entity Type | 01 - Individual |
Address | DE |
Party Name | NOT AVAILABLE |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 01 - Individual |
Address | DE |
Party Name | NOT AVAILABLE |
Party Type | 10 - Original Applicant |
Legal Entity Type | 01 - Individual |
Address | DE |
Event Date | Event Description |
Monday, February 20, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
Thursday, January 26, 2023 | FINAL DISPOSITION NOTICE SENT TO IB |
Thursday, January 26, 2023 | FINAL DISPOSITION PROCESSED |
Wednesday, January 4, 2023 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Tuesday, October 4, 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Tuesday, October 4, 2022 | REGISTERED-PRINCIPAL REGISTER |
Monday, July 25, 2022 | NOTIFICATION PROCESSED BY IB |
Tuesday, July 19, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, July 19, 2022 | PUBLISHED FOR OPPOSITION |
Wednesday, June 29, 2022 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Wednesday, June 29, 2022 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Wednesday, June 29, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Wednesday, June 15, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, June 9, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, June 8, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, June 8, 2022 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Wednesday, December 22, 2021 | NOTIFICATION OF FINAL REFUSAL EMAILED |
Wednesday, December 22, 2021 | FINAL REFUSAL E-MAILED |
Wednesday, December 22, 2021 | FINAL REFUSAL WRITTEN |
Tuesday, December 21, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Monday, December 20, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Monday, December 20, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Monday, July 19, 2021 | REFUSAL PROCESSED BY IB |
Monday, June 28, 2021 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Monday, June 28, 2021 | REFUSAL PROCESSED BY MPU |
Friday, June 18, 2021 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Thursday, June 17, 2021 | NON-FINAL ACTION WRITTEN |
Wednesday, June 16, 2021 | ASSIGNED TO EXAMINER |
Tuesday, May 25, 2021 | APPLICATION FILING RECEIPT MAILED |
Friday, May 21, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Thursday, May 20, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |